BLACK DIAMOND THERAPEUTICS, INC. (BDTX) Operating cash flow 2018–2025
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$29.6MFY2025 · since FY2018: -$8.5M → $29.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $29.6M | +147.5% |
| FY2024 | -$62.3M | +6.6% |
| FY2023 | -$66.7M | +21.6% |
| FY2022 | -$85.1M | +15.0% |
| FY2021 | -$100.1M | -92.1% |
| FY2020 | -$52.1M | -111.3% |
| FY2019 | -$24.7M | -191.9% |
| FY2018 | -$8.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice